Ignite Creation Date:
2024-05-05 @ 5:00 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00362765
Status:
TERMINATED
Last Update Posted:
2008-08-13
First Post:
2006-08-09
Brief Title:
Fenofibrate and Metformin Insulin Sensitivity in Type 2 Diabetics Study
Sponsor:
Solvay Pharmaceuticals
Organization:
Solvay Pharmaceuticals
Study Overview
Official Title:
Assessment of Insulin Sensitivity in Type 2 Diabetics Treated With Metformin Fenofibrate and Their Combination
Status:
TERMINATED
Status Verified Date:
2008-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
The study was prematurely terminated due to difficulties in the recruitment of T2DM patients who are not under statin therapy at inclusion
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Double-blind randomized placebo-controlled study in type 2 diabetes and dyslipidemic patientsPatients will be randomized to one of four treatment arms for 16 weeks placebo fenofibrate metformin or metformin and fenofibrate combination
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2005-003347-31 | None | None | None |